BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 22508445)

  • 1. Nanomaterials for ocular drug delivery.
    Liu S; Jones L; Gu FX
    Macromol Biosci; 2012 May; 12(5):608-20. PubMed ID: 22508445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology in ocular drug delivery.
    Sahoo SK; Dilnawaz F; Krishnakumar S
    Drug Discov Today; 2008 Feb; 13(3-4):144-51. PubMed ID: 18275912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in ocular drug delivery.
    Rawas-Qalaji M; Williams CA
    Curr Eye Res; 2012 May; 37(5):345-56. PubMed ID: 22510004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical delivery of ocular therapeutics: carrier systems and physical methods.
    Souza JG; Dias K; Pereira TA; Bernardi DS; Lopez RF
    J Pharm Pharmacol; 2014 Apr; 66(4):507-30. PubMed ID: 24635555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and future ophthalmic drug delivery systems. A shift to the posterior segment.
    Del Amo EM; Urtti A
    Drug Discov Today; 2008 Feb; 13(3-4):135-43. PubMed ID: 18275911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in ophthalmic drug delivery.
    Morrison PW; Khutoryanskiy VV
    Ther Deliv; 2014 Dec; 5(12):1297-315. PubMed ID: 25531930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advance of the application of nano-controlled release system in ophthalmic drug delivery.
    Wang X; Wang S; Zhang Y
    Drug Deliv; 2016 Oct; 23(8):2897-2901. PubMed ID: 26635087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micelles: Promising Ocular Drug Carriers for Anterior and Posterior Segment Diseases.
    Durgun ME; Güngör S; Özsoy Y
    J Ocul Pharmacol Ther; 2020; 36(6):323-341. PubMed ID: 32310723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug delivery to the posterior segment of the eye.
    Thrimawithana TR; Young S; Bunt CR; Green C; Alany RG
    Drug Discov Today; 2011 Mar; 16(5-6):270-7. PubMed ID: 21167306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in ocular drug delivery.
    Chen H
    J Drug Target; 2015; 23(7-8):597-604. PubMed ID: 26453157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.
    Jiao J
    Adv Drug Deliv Rev; 2008 Dec; 60(15):1663-73. PubMed ID: 18845195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendrimers for gene delivery--a potential approach for ocular therapy?
    Chaplot SP; Rupenthal ID
    J Pharm Pharmacol; 2014 Apr; 66(4):542-56. PubMed ID: 24635556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.
    Mandal A; Bisht R; Rupenthal ID; Mitra AK
    J Control Release; 2017 Feb; 248():96-116. PubMed ID: 28087407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent patents and advances in ophthalmic drug delivery.
    Janoria KG; Hariharan S; Dasari CR; Mitra AK
    Recent Pat Drug Deliv Formul; 2007; 1(2):161-70. PubMed ID: 19075883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Potential of liposomes for the intravitreal injection of therapeutic molecules].
    Bochot A; Lajavardi L; Camelo S; Bourges JL; Behar-Cohen F; de Kozak Y; Fattal E
    Ann Pharm Fr; 2011 Mar; 69(2):100-7. PubMed ID: 21440102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.
    Choonara YE; Pillay V; Danckwerts MP; Carmichael TR; du Toit LC
    J Pharm Sci; 2010 May; 99(5):2219-39. PubMed ID: 19894268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.
    Shree D; Patra CN; Sahoo BM
    Pharm Nanotechnol; 2024; 12(3):229-250. PubMed ID: 37587812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic core-shell systems as soft drug delivery nanocarriers.
    Lukowiak MC; Thota BN; Haag R
    Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1327-41. PubMed ID: 25868804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendrimer nanoparticles for ocular drug delivery.
    Kambhampati SP; Kannan RM
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):151-65. PubMed ID: 23410062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.